These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Durability of results obtained with transurethral microwave thermotherapy in the treatment of men with symptomatic benign prostatic hyperplasia. Ramsey EW; Dahlstrand C J Endourol; 2000 Oct; 14(8):671-5. PubMed ID: 11083410 [TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of new treatments for benign prostatic hyperplasia: results of a randomized trial comparing the short-term cost-effectiveness of transurethral interstitial laser coagulation of the prostate, transurethral microwave thermotherapy and standard transurethral resection or incision of the prostate. Nørby B; Nielsen HV; Frimodt-Møller PC Scand J Urol Nephrol; 2002; 36(4):286-95. PubMed ID: 12201922 [TBL] [Abstract][Full Text] [Related]
24. [Transurethral microwave-thermotherapy in the treatment of benign prostatic hyperplasia]. de Wildt MJ; de la Rosette JJ; Froeling FM; Bloem FA; Laduc R; Debruyne FM Ned Tijdschr Geneeskd; 1994 Aug; 138(35):1764-70. PubMed ID: 7523961 [TBL] [Abstract][Full Text] [Related]
25. Transurethral microwave thermotherapy (TUMT) in benign prostatic hyperplasia: placebo versus TUMT. de la Rosette JJ; de Wildt MJ; Alivizatos G; Froeling FM; Debruyne FM Urology; 1994 Jul; 44(1):58-63. PubMed ID: 7518982 [TBL] [Abstract][Full Text] [Related]
26. Multicenter initial U.S. experience with CoreTherm-monitored feedback transurethral microwave thermotherapy for individualized treatment of patients with symptomatic benign prostatic hyperplasia. David RD; Grunberger I; Shore N; Swierzewski SJ J Endourol; 2004 Sep; 18(7):682-5. PubMed ID: 15597663 [TBL] [Abstract][Full Text] [Related]
28. Relation between intraprostatic temperature and clinical outcome in microwave thermotherapy. Carter S; Tubaro A J Endourol; 2000 Oct; 14(8):617-25. PubMed ID: 11083403 [TBL] [Abstract][Full Text] [Related]
29. Does transurethral microwave thermotherapy have a different effect on prostate cancer than on benign or hyperplastic tissue? Khair AA; Pacelli A; Iczkowski KA; Cheng L; Corica FA; Larson TR; Corica A; Bostwick DG Urology; 1999 Jul; 54(1):67-72. PubMed ID: 10414729 [TBL] [Abstract][Full Text] [Related]
30. Temporary urethral stenting after high-energy transurethral microwave thermotherapy of the prostate. Devonec M; Dahlstrand C World J Urol; 1998; 16(2):120-3. PubMed ID: 12073225 [TBL] [Abstract][Full Text] [Related]
31. [Prevention of temporary prostatic obstruction after high-energy microwave thermothery by placement of prostatic bridge catheter]. Djavan B; Seitz C; Fakhari M; Ghawidel K; Marberger M Prog Urol; 1999 Apr; 9(2):261-70. PubMed ID: 10370950 [TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up of transurethral microwave thermotherapy. Lau KO; Li MK; Foo KT Urology; 1998 Nov; 52(5):829-33. PubMed ID: 9801108 [TBL] [Abstract][Full Text] [Related]
33. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: durability of response. Baba S; Nakamura K; Tachibana M; Murai M Urology; 1996 May; 47(5):664-71. PubMed ID: 8650863 [TBL] [Abstract][Full Text] [Related]
34. Transurethral microwave thermotherapy for symptomatic benign prostatic hyperplasia: long-term durability with Prostcare. Tsai YS; Lin JS; Tong YC; Tzai TS; Yang WH; Chang CC; Cheng HL; Lin YM; Jou YC Eur Urol; 2001 Jun; 39(6):688-92; discussion 693-4. PubMed ID: 11464059 [TBL] [Abstract][Full Text] [Related]